BBS Pharmaceuticals, a licensed cultivator and manufacturer of medicinal cannabis products would like to congratulate Minister David Littleproud and the Australian Parliament in passing the Export […]
It was our great honour to host The Hon. David Ridgway, Minister of Trade and Investment, at BBS’s cultivation and production facility. Together with BBS’s Corporate […]
Australia has published a framework for new CBD regulations as it considers relaxing its narcotics scheduling of cannabidiol to make it available over the counter in […]
The Australian Senate Committee has revealed their recommendations from the inquiry ‘Current barriers to patient access to medicinal cannabis in Australia’. In its 118-page long document, […]
Even on a good day, eight-year-old Sophie Martin has hundreds of seizures. When she has a severe seizure, she turns blue and cannot breathe. She has […]
Don’t bring others down! Message from BBS Pharmaceuticals’ CEO, John Dagas regarding the medicinal cannabis industry. “The start of 2020 has seen a number of medicinal […]
“Medicinal cannabis can be the healthcare success story of our lifetime,” says Hugh Hempel, a technology industry veteran turned health care entrepreneur. In this moving talk, […]